EP0647850A3 - Treatment of lipoprotein containing samples. - Google Patents

Treatment of lipoprotein containing samples. Download PDF

Info

Publication number
EP0647850A3
EP0647850A3 EP94890160A EP94890160A EP0647850A3 EP 0647850 A3 EP0647850 A3 EP 0647850A3 EP 94890160 A EP94890160 A EP 94890160A EP 94890160 A EP94890160 A EP 94890160A EP 0647850 A3 EP0647850 A3 EP 0647850A3
Authority
EP
European Patent Office
Prior art keywords
containing samples
treatment
lipoprotein containing
lipoprotein
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP94890160A
Other languages
German (de)
French (fr)
Other versions
EP0647850A2 (en
EP0647850B1 (en
Inventor
Ewald Dr Molinari
Peter Dipl-Ing Pichler
Hartmut Dr Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Publication of EP0647850A2 publication Critical patent/EP0647850A2/en
Publication of EP0647850A3 publication Critical patent/EP0647850A3/en
Application granted granted Critical
Publication of EP0647850B1 publication Critical patent/EP0647850B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Abstract

The present invention relates to a sample treatment composition for lipoprotein-containing samples and for immunochemical determination of an antigen, where the composition contains a diluting buffer with a content of an amino acid, where appropriate with a content of a reaction accelerator, and antibodies against the antigen to be determined. <IMAGE>
EP94890160A 1993-10-11 1994-10-05 Treatment of lipoprotein containing samples Expired - Lifetime EP0647850B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT2043/93 1993-10-11
AT204393 1993-10-11
AT0204393A AT400199B (en) 1993-10-11 1993-10-11 TREATMENT OF LIPOPROTE CONTAINING SAMPLES

Publications (3)

Publication Number Publication Date
EP0647850A2 EP0647850A2 (en) 1995-04-12
EP0647850A3 true EP0647850A3 (en) 1996-07-31
EP0647850B1 EP0647850B1 (en) 2001-01-17

Family

ID=3526548

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94890160A Expired - Lifetime EP0647850B1 (en) 1993-10-11 1994-10-05 Treatment of lipoprotein containing samples

Country Status (5)

Country Link
EP (1) EP0647850B1 (en)
JP (1) JPH07181182A (en)
AT (2) AT400199B (en)
CA (1) CA2117745A1 (en)
DE (1) DE59409638D1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790018C (en) * 2006-12-21 2015-02-03 Amgen Inc. Formulations
EP2156174B1 (en) * 2007-06-08 2015-05-20 Quest Diagnostics Investments Incorporated Method for purification of lipoproteins
JP5093087B2 (en) * 2008-12-18 2012-12-05 東ソー株式会社 Method for enhancing immune response with polyethylene glycol and urea

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058959A1 (en) * 1981-02-25 1982-09-01 Roche Diagnostics GmbH Method for preparing low-turbidity standard or reference sera
DE3329952A1 (en) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg METHOD FOR REDUCING TURBIDITY IN CONTROL SERIES
DE3330770A1 (en) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg METHOD FOR PASTEURIZING HUMAN PLASMA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62261962A (en) * 1986-05-08 1987-11-14 Chemo Sero Therapeut Res Inst Liquid control serum for lipid component

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058959A1 (en) * 1981-02-25 1982-09-01 Roche Diagnostics GmbH Method for preparing low-turbidity standard or reference sera
DE3329952A1 (en) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg METHOD FOR REDUCING TURBIDITY IN CONTROL SERIES
EP0141922A1 (en) * 1983-08-19 1985-05-22 BEHRINGWERKE Aktiengesellschaft Method of decreasing turbidity in control sera
DE3330770A1 (en) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg METHOD FOR PASTEURIZING HUMAN PLASMA

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAZZOLATO: "The determination of lipoprotein Lp(a) by rate and endpoint nephelometry", CLINICA CHIMICA ACTA, vol. 135, 1983, AMSTERDAM, pages 203 - 208, XP000195977 *

Also Published As

Publication number Publication date
ATA204393A (en) 1995-02-15
EP0647850A2 (en) 1995-04-12
JPH07181182A (en) 1995-07-21
AT400199B (en) 1995-10-25
DE59409638D1 (en) 2001-02-22
ATE198797T1 (en) 2001-02-15
CA2117745A1 (en) 1995-04-12
EP0647850B1 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
AU6816694A (en) Simple immunochemical semiquantitative assay method and apparatus
GR3018907T3 (en) Protein precipitation reagent.
AU3090889A (en) Method for determination of a polyvalent substance using an immunoaggregate
EP0930366A3 (en) Binding domains in delta proteins
BR9712298A (en) Polypeptide, DNA molecule, recombinant expression vector, host cell, process to detect infection by m. tuberculosis in a biological sample, diagnostic kit, monoclonal, and, polyclonal, and, fusion protein
EP0902286A3 (en) Immunoassay utilizing two incubations with labelled antigen
AU7578087A (en) Process and agent for the detection of an analyte
EP0647850A3 (en) Treatment of lipoprotein containing samples.
AU8472891A (en) Immunological precipitation process for the determination of a bindable analyte, as well as a reagent for carrying out this process
Rush et al. Measurement of human dopamine-beta-hydroxylase in serum by homologous radioimmunoassay.
AU638155B2 (en) Peptides with a characteristic antigenic determinant for alphal-microglobulin
GR3005066T3 (en)
GB9403215D0 (en) Chemical modification of antibodies and antigens
US6706486B1 (en) Method for the quantitative release of natural or recombinant proteins, polypeptides or peptides
ES2056041T1 (en) PROCEDURE FOR THE DETERMINATION OF ANTIBODIES AND ANTIGENS.
IE830752L (en) A method for the determination of antigens
EP0332021A3 (en) Agent containing amino oxide for use in immuno assays
EP0343592A3 (en) Method and reagent for the determination of iron
FI943816A (en) Method and apparatus for the determination of antibodies
AU653182B2 (en) Process for selective removal of salivary alpha-amylase and assay for pancreatic alpha-amylase
GB8724549D0 (en) Immunoassay
WO2001031336A3 (en) Immunoassay of c-peptide containing impurities in human insulin
ZA955916B (en) Method for determining the lysine content of seeds
FI102217B1 (en) Method for detection of Pseudomonas aeruginosa serotypes in a sample in vitro by means of monoclonal antibodies, monoclonal antibodies employable in the method and a test set employable in the method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19961028

17Q First examination report despatched

Effective date: 19981228

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAXTER AKTIENGESELLSCHAFT

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAXTER AKTIENGESELLSCHAFT

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TECHNOCLONE GESELLSCHAFT M.B.H.

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20010117

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20010117

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20010117

Ref country code: GB

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20010117

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20010117

Ref country code: ES

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 20010117

REF Corresponds to:

Ref document number: 198797

Country of ref document: AT

Date of ref document: 20010215

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 59409638

Country of ref document: DE

Date of ref document: 20010222

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20010417

EN Fr: translation not filed
NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
GBV Gb: ep patent (uk) treated as always having been void in accordance with gb section 77(7)/1977 [no translation filed]

Effective date: 20010117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011031

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011031

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
BERE Be: lapsed

Owner name: TECHNOCLONE G.M.B.H.

Effective date: 20011031

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020702